Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos

Diabetes

Volumn 52, Issue 5, 2003, Pages 1222-1228

  Wentzel, Parri ^a   Ejdesjö, Andreas ^b   Eriksson, Ulf J ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); EMBRYO; EMBRYOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; MATERNAL DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; TERATOGENICITY; TERATOLOGY;

ABNORMALITIES; ANIMALS; CATTLE; DIABETES MELLITUS, EXPERIMENTAL; EMBRYO; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HYPERGLYCEMIA; ORGAN CULTURE TECHNIQUES; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 0037406474     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1222     Document Type: Article

References (61)

1. Pedersen J: The Pregnant Diabetic and Her Newborn: Problems and Management. 2nd ed. Copenhagen, Munksgaard, 1977
2. Sadler TW, Hunter ES, Wynn RE, Phillips LS: Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes 38:70-74, 1989
3. Eriksson UJ, Borg LAH: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
4. Buchanan TA, Denno KM, Sipos GF, Sadler TW: Diabetic teratogenesis: in vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43:656-660, 1994
5. Wentzel P, Eriksson UJ: Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats. Eur J Endocrinol 134:459-446, 1996
6. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
7. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Kondo T, Nagataki S: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998, 1995
8. Cederberg J, Eriksson UJ: Decreased catalase activity in malformationprone embryos of diabetic rats. Teratology 56:350-357, 1997
9. Eriksson UJ, Simán CM: Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in the offspring. Diabetes 45:1497-1502, 1996
10. Viana M, Herrera E, Bonet B: Teratogenic effects of diabetes mellitus in the rat: prevention with vitamin E. Diabetologia 39:1041-1046, 1996
11. Simán CM, Eriksson UJ: Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 40:1416-1424, 1997
12. Wiznitzer A, Ayalon N, Hershkovitz R, Khamaisi M, Reece EA, Trischler H, Bashan N: Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol 180:188-193, 1999
13. Sakamaki H, Akazawa S, Ishibashi M, Izumino K, Takino H, Yamasaki H, Yamaguchi Y, Goto S, Urata Y, Kondo T, Nagataki S: Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48:1138-1144, 1999
14. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
15. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
16. Janero DR, Hreniuk D, Sharif HM: Hydroperoxide-induced oxidative stress impairs heart muscle cell carbohydrate metabolism. Am J Physiol 266: C179-C188, 1994
17. Rivera-Nieves J, Thompson WC, Levine RL, Moss J: Thiols mediate superoxide-dependent NADH modification of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274:19525-19531, 1999
18. Ishii T, Sunami O, Nakajima H, Nishio H, Takeuchi T, Hata F: Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide. Biochem Pharmacol 58:133-143, 1999
19. Morgan PE, Dean RT, Davies MJ: Inhibition of glyceraldehyde-3-phosphate dehydrogenase by peptide and protein peroxides generated by singlet oxygen attack. Eur J Biochem 269:1916-1925, 2002
20. McKenzie SM, Doe WF, Buffinton GD: 5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells. Gut 44:180-185, 1999
21. Danshina PV, Schmalhausen EV, Avetisyan AV, Muronetz VI: Mildly oxidized glyceraldehyde-3-phosphate dehydrogenase as a possible regulator of glycolysis. IUBMB Life 51:309-314, 2001
22. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
23. Sirover MA: New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-184, 1999
24. Ito Y, Pagano PJ, Tornheim K, Brecher P, Cohen RA: Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta. Am J Physiol 270:H81-H87, 1996
25. Berry MD, Boulton AA: Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J Neurosci Res 60:150-154, 2000
26. Eriksson UJ, Dahlstrom E, Larsson KS, Hellerstrom C: Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31:1-6, 1982
27. Siman CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ: Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 61:355-367, 2000
28. Wentzel P, Welsh N, Eriksson UJ: Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered PGE2 levels in rat embryos exposed to a diabetic environment. Diabetes 48:813-820, 1999
29. Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37:365-374, 1988
30. New DA: New DA. Whole-embryo culture and the study of mammalian embryos during organogenesis (Review). Biol Rev Camb Philos Soc 53:81-122, 1978
31. Wentzel P, Thunberg L, Eriksson UJ: Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14, 1997
32. Lowry OH, Rosebrough. NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
33. Kissane JM, Robins E: The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 233:184-188, 1958
34. Hinegardner RT: An improved fluorometric assay for DNA. Anal Biochem 39:197-201, 1971
35. Bergmeyer HU: Methods of Enzymatic Analysis. Weinheim, Germany, Verlag Chemie, 1983, p. 211-213
36. Mohamed AO, Ronquist G, al Bayoumi R: Increased membrane activity of glyceraldehyde 3-phosphate dehydrogenase in erythrocytes of patients with homozygous sickle cell anaemia. Clin Chim Acta 209:189-195, 1992
37. Ceriello A, Bortolotti N, Falleti E, Taboga C, Tonutti L, Crescentini A, Motz E, Lizzio S, Russo A, Bartoli E: Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 20:194-197, 1997
38. West IC: Radicals and oxidative stress in diabetes. Diabet Med 17:171-180, 2000
39. Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24:733-737, 2001
40. Ceriello A: Nitrotyrosine: new findings as a marker of postprandial oxidative stress. Int J Clin Pract Suppl Jul:51-58, 2002
41. Myatt L, Kossenjans W, Sahay R, Eis A, Brockman D: Oxidative stress causes vascular dysfunction in the placenta. J Matern Fetal Med 9:79-82, 2000
42. Cederberg J, Siman CM, Eriksson UJ: Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 49:755-762, 2001
43. Persson B: Prevention of fetal malformation with antioxidants in diabetic pregnancy. Pediatr Res 49:742-743, 2001
44. Cederberg J, Basu S, Eriksson UJ: Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 44:766-774, 2001
45. Lee AT, Plump A, DeSimone C, Cerami A, Bucala R: A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos. Diabetes 44:20-24, 1995
46. Lee AT, Reis D, Eriksson UJ: Hyperglycemia induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo. Diabetes 48:371-376, 1999
47. Hiranruengchok R, Harris C: Diamide-induced alterations of intracellular thiol status and the regulation of glucose metabolism in the developing rat conceptus in vitro. Teratology 52:205-214, 1995
48. Ornoy A, Zaken V, Kohen R: Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies. Teratology 60:376-386, 1999
49. Zaken V, Kohen R, Ornoy A: Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium. Teratology 64:33-44, 2001
50. Novotny MV, Yancey MF, Stuart R, Wiesler D, Peterson RG: Inhibition of glycolytic enzymes by endogenous aldehydes: a possible relation to diabetic neuropathies. Biochim Biophys Acta 1226:145-150, 1994
51. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348, 2001
52. Eriksson UJ, Naeser P, Brolin SE: Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes 35:1356-1363, 1986
53. Hod M, Star S, Passonneau JV, Unterman TG, Freinkel N: Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Commun 140:974-980, 1986
54. Hashimoto M, Akazawa S, Akazawa M, Akashi M, Yamamoto H, Maeda Y, Yamaguchi Y, Yamasaki H, Tahara D, Nakanishi T, Nagataki S: Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 33:597-602, 1990
55. Loeken MR, Horal M: Regulation of transcription and morphogenesis by glucosamine: does hexosamine flux mediate the molecular effects of high glucose metabolism on embryogenesis? (Abstract). Diabetes 49 (Suppl. 1):A274, 2000
56. Eriksson UJ, Wentzel P, Minhas HS, Thornalley PJ: Teratogenicity of 3-deoxyglucosone and diabetic embryopathy. Diabetes 47:1960-1966, 1998
57. Hiramatsu Y, Sekiguchi N, Hayashi M, Isshiki K, Yokota T, King GL, Loeken MR: Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 51:2804-2810, 2002
58. Wentzel P, Wentzel CR, Gareskog MB, Eriksson UJ: Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63:193-201, 2001
59. Alcazar O, Qiu-yue Z, Gine E, Tamarit-Rodriguez J: Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid. Diabetes 46:1153-1158, 1997
60. Kim JR, Kwon KS, Yoon HW, Lee SR, Rhee SG: Oxidation of proteinaceous cysteine residues by dopamine-derived H2O2 in PC12 cells. Arch Biochem Biophys 397:414-423, 2002
61. Matthews RT, Ferrante RJ, Jenkins BG, Browne SE, Goetz K, Berger S, Chen IY, Beal MF: Iodoacetate produces striatal excitotoxic lesions. J Neurochem 69:285-289, 1997